• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION VERIFY ENHANCED; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION VERIFY ENHANCED; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON Back to Search Results
Model Number 353101
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/08/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Continuation of d10: product id 306001, lot# unknown, implanted: (b)(6) 2024, product type screening device.Product id 306001, lot# unknown, implanted: (b)(6) 2024, product type screening device.Section d information references the main component of the system.Other relevant device(s) are: product id: 306001, serial/lot #: unknown.Product id: 306001, serial/lot #: unknown.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Information was received from a trial patient who was using an external neurostimulator (ens) for urgency frequency.Their trial started on (b)(6) 2024.Additional information was received from the patient on (b)(6) 2024 stating that the leads have dislodged.Additional information was received from the patient on 2024-sep-11 stating that their device was removed early as a result of the leads becoming dislodged and unable to reconnect.Additional information was received from the healthcare provider (hcp) stating that the patient had their post op appointment on (b)(6) 2024 and went home and has not been seen since then.The patient does not want to proceed with stage 2 trial.
 
Additional Manufacturer Narrative
Continuation of d10: product id 306001, lot# unknown, implanted: (b)(6) 2024, product type screening device, product id 306001, lot# unknown, implanted: (b)(6) 2024, product type screening device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information was received from the healthcare provider (hcp) stating that the patient had their post op appointment on (b)(6) 2024 and went home and has not been seen since then.The patient does not want to proceed with stage 2 trial.
 
Additional Manufacturer Narrative
Continuation of d10: product id: 306001, lot# unknown, implanted: (b)(6) 2024, product type screening device, product id 306001, lot# unknown, implanted: (b)(6) 2024, product type screening device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Continuation of d10: product id 306001 lot# 60565992, implanted: (b)(6) 2024, product type screening device product id 306001 lot# 60570948, implanted: (b)(6) 2024, explanted: product type screening device medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERIFY ENHANCED
Common Device Name
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCON
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
justin ellis
8200 coral sea street ne mvs21
mounds view, MN 55112
7635265677
MDR Report Key20375645
Report Number2182207-2024-04114
Device Sequence Number17080199
Product Code EZW
UDI-Device Identifier00763000879280
UDI-Public00763000879280
Combination Product (Y/N)N
Initial Reporter StateAR
Initial Reporter CountryUS
PMA/510(K) Number
P970004
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 11/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number353101
Device Catalogue Number353101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/10/2024
Supplement Date Received by Manufacturer10/04/2024
10/11/2024
11/20/2024
Initial Report FDA Received Date10/04/2024
Supplement Report FDA Received Date11/03/2024
11/03/2024
11/29/2024
Date Device Manufactured07/12/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
"SEE H11....".
Patient Age72 YR
Patient SexMale
-
-